2,829 followers
While anti-TNFa use is associated with increased histoplasmosis risk, the incidence is still very very low. For instance, infliximab (Remicade) incidence is estimated at 18.78 per 100,000 people, and etanercept (Enbrel) at 2.65 per 100,000 people. https:/